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Favorable and unfavorable outcomes
A B S T R A C T
Background: Pakistan implemented initiatives to detect tuberculosis (TB) patients through extended
contact screening (ECS); it improved case detection but treatment outcomes need assessment.
Objectives: To compare treatment outcomes of pulmonary TB (PTB) patients detected by ECS with those
detected by routine passive case finding (PCF).
Methods: A cohort study using secondary program data conducted in Lahore, Faisalabad and Rawalpindi
districts and Islamabad in 2013–15. We used log binomial regression models to assess if ECS was
associated with unfavorable treatment outcomes (death, loss-to-follow-up, failure, not evaluated) after
adjusting for potential confounders.
Results: We included 79,431 people with PTB; 4604 (5.8%) were detected by ECS with 4052 (88%)
bacteriologically confirmed. In all PTB patients the proportion with unfavorable outcomes was not
significantly different in ECS group (9.6%) compared to PCF (9.9%), however, among bacteriologically
confirmed patients unfavorable outcomes were significantly lower in ECS (9.9%) than PCF group (11.6%,
P = 0.001). ECS was associated with a lower risk of unfavorable outcomes (adjusted relative risk (aRR)
0.90; 95% CI 0.82–0.99) among ‘all PTB’ patients and bacteriologically confirmed PTB patients (aRR 0.91;
95% CI 0.82–1.00).
Conclusion: In PTB patients detected by ECS the treatment outcomes were not inferior to those detected
by PCF.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction
Pakistan has a high burden of tuberculosis (TB) with an
estimated 5,70,000 incident TB patients and 42,000 deaths in
2019; only 58% of the estimated patients were diagnosed, notified
and started on treatment (World Health Organization, 2020a).
Therefore, complementing standard “passive” case finding
with active case finding has been strongly encouraged (Ho et al.,
2016; World Health Organization, 2013). A cluster-randomized
controlled trial conducted in Vietnam in 2010–15 showed that
household-contact investigation with standard passive case
finding was more effective than standard passive case finding
alone for the detection of TB in a high-prevalence setting (Fox et al.,
2018).
Contact tracing and screening initiatives among contacts of TB
patient, including in urban slums, have shown an increase in case
detection and notification and therefore an opportunity to reduce
diagnostic delay (Dowdy et al., 2013; Fatima et al., 2014; Lorent
et al., 2014; Miller et al., 2010; World Health Organization, 2012,
2011).
The National TB control program (NTP) of Pakistan achieved
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by 2005 with the DOTS strategy (Directly Observed Treatment,























































M. Ul Haq, S.G. Hinderaker, R. Fatima et al. International Journal of Infectious Diseases 104 (2021) 634–640uberculosis Programme, 2019a). The majority of the case
nding is through the public sector (National Tuberculosis
rogramme, 2019b) where people with presumptive TB come to
 public health facility and are investigated for TB; this is called
passive case finding” (PCF) and the initiative comes from the
atients. Often such patients are referred by the private health
ector where diagnostic services are not available. Other
atients who do not visit the health facility despite having
ymptoms may be identified by “active case finding (ACF)”,
here the health system tries to reach out into the community
o identify and diagnose patients with TB (World Health
rganization, 2012). ACF is also done in populations with high
revalence of undetected TB or in marginalized and vulnerable
opulations with poor access to health services (World Health
rganization, 2013).
Pakistan NTP implemented an innovative type of ACF, an
xtended contact screening’ (ECS) strategy. This involved commu-
ity contact investigation beyond the routine household contacts:
ll individuals in households within a 50-m radius from the home
f an index smear-positive TB patient were asked about TB
ymptoms; if they had symptoms they were investigated. The ECS
trategy increased case finding by around 8%, which is more than
xpected from normal annual increases in routine TB control
Fatima et al., 2016).
However, there has been no assessment on whether ECS
ffected the treatment outcomes. A systematic review published
n 2013 identified similar treatment outcomes among ACF and PCF-
etected patients (Lönnroth et al., 2013); while more recent papers
how ACF to have similar (Khaing et al., 2018; Shewade et al., 2019)
r worse outcomes (Sengai et al., 2020; Singh et al., 2020). We have
ot found any study from Pakistan comparing treatment outcomes
y case detection strategy.
Therefore, our objective was to compare the treatment
utcomes of TB patients detected by the ECS strategy with those
etected in routine PCF in selected districts of Pakistan.
ethods
tudy design




Pakistan has a population of over 200 million (WorldBank,
018). The health system includes government (public) institu-
ions, parastatal health institutions (armed forces, Sui Gas, WAPDA
Pakistan Water and Power Development Authority), Railways,
auji Foundation), the private sector, civil society and philanthrop-
c institutions. The private sector is large and unregulated, with
ualified and unqualified health service providers that deliver
eneral curative services to about 75% of Pakistan’s population;
early 90% of patients with TB initially seek care in the private
ector (Fatima et al., 2017).
Public health care is delivered through a network of primary,
econdary and tertiary level health facilities. The primary health
are facilities include civil dispensaries, basic health units, rural
ealth centers, mother-child healthcare centers, urban health
basic health units. A BMU has a staffed laboratory doing smear
microscopy (a few facilities also do Xpert MTB/RIF assays) and a
doctor/qualified medical staff trained to diagnose and initiate TB
treatment. TB treatment involves 6–8 months of treatment
provided under daily direct observation by a health care provider,
a community volunteer or a family member. The BMU is also a
facility where TB patients return for re-examinations and
confirmation of cure. The BMU maintains records in standard
formats and provides periodic reports to the district coordinator,
including reports on treatment outcome (World Health Organi-
zation, 2020b). Sputum microscopy services, Xpert MTB/RIF
testing and TB treatment are provided free of charge. During
2013–15, all the BMUs followed the algorithm in Figure 1 to
diagnose TB.
All the patients in this study were treated in line with national
TB guidelines (2013–15) and under direct observation as is routine
for PCF. New patients (never been treated before or treated <30
days) were treated with 6 months’ treatment regimen, which
consisted of 2 months of HRZE (H-Isoniazid, R-Rifampicin
Z-Pyrazinamide, E-Ethambutol) in intensive phase and 4 months
of HR in continuation phase. Previously treated patients (treated
for >30 days in the past) were treated with 8 months’ regimen that
consisted of 2 months HRZES (S-Streptomycin), 1 month HRZE and
5 months of HRE. Patients who were diagnosed as having
rifampicin resistance were referred to drug-resistant TB sites for
second line treatment. HIV testing was not routinely offered to
patients (PCF or ECS).
Extended contact screening
During 2013–15, ECS was implemented in 4 mainly urban
districts: Lahore, Rawalpindi, Faisalabad and Islamabad. (Figure 2).
There were 98 BMUs for the population of 18 million. More than
80% of the population in these districts live in urban areas. The
average socio-economic status of people living in the project
districts is better than the average of Pakistan because of better
jobs and business opportunities. However, half of the population
live in slums with poor socio-economic conditions.
The Pakistan NTP had a project funded by TB-REACH wave III,
intended to facilitate detection of more TB cases (Fatima et al.,
2016).
All people staying within a 50-m radius (ascertained using
geographic information system, GIS) from the households of
known TB patients were contacted and screened for TB by trained
project staff. A 50-m radius was chosen based on the data from the
electronic TB surveillance system which revealed the presence of
many cases coming from the same family, same address, or
neighboring areas; suggesting high rates of geographical cluster-
ing. The approximate number of households in this radius was
deemed feasible to be covered under close community screening
by the NTP. Mobile phones enabled with ARC GIS (version 10)
software were used by field workers to identify households within
a 50-m radius of the index case and collect data. All available
people permanently residing within a 50-m radius were contacted.
The participants were informed about a TB patient in the
neighborhood (50-m radius) but care was taken not to disclose
the name. Measures were taken to safeguard the confidentiality of
the index patient. Any person with a productive cough for more
than 2 weeks was defined as a ‘presumptive TB’ patient. One spot
sputum sample was collected and transported to the closest BMU
for diagnostic testing. The same diagnostic algorithm as mentionednits, and urban health centers. The secondary level health care
acilities comprise sub-district hospitals and district hospitals.
ertiary level health care is provided through teaching and
pecialized hospitals.
TB basic management units (BMUs) are located at the district
nd sub-district hospitals, the rural health centers, and some63in Figure 1 was followed except for the use of Xpert MTB/RIF
(if available) assay among sputum smear microscopy negative
presumptive TB. Patients bacteriologically positive for TB were
contacted by the project staff and referred to the nearest BMU for
registration and treatment initiation. All presumptive TB patients
aged <15 years were referred to specialist pediatric care for5
M. Ul Haq, S.G. Hinderaker, R. Fatima et al. International Journal of Infectious Diseases 104 (2021) 634–640Figure 2. Map of Pakistan showing the 4 selected districts for extended contact screening for tuberculosis (2013–15).
Figure 1. Algorithm used by Pakistan NTP for assessing a patient with presumptive tuberculosis in routine (PCF) program (2013–15).
TB = tuberculosis, sm+ve = Smear positive, sm-ve = Smear negative, FLD = First Line Drug, CXR = Chest X-ray, MTB = Mycobacterium tuberculosis, RR = Rifampicin resistant,
SLD = Second line drug.diagnosis and management. People whose sputum tested negative
on both microscopy and X-pert MTB/RIF were referred to the
nearest BMU for follow-up according to national guidelines.
Patients identified by ECS were marked “TB REACH” in the TB
register.636Study population
We included all people with pulmonary TB (PTB) registered and
treated at public or private facility engaged with the NTP in Lahore,
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etected by PCF or by ECS. The cases identified through ECS were
arked as “TB REACH” in the TB registers at facility level and their
egistration for treatment was assured by the field health officers.
ll patients were considered as PCF unless referred by TB REACH
ave III project field health workers (through household and
ommunity-based contact screening). This was confirmed by
eviewing the project records. Patients with known rifampicin
esistance and treated with second-line drugs were not included.
ata variables and sources
Case-based data was entered from facility-based TB registers
nto MS Excel. For quality assurance, our database was compared
ith aggregated data in the routine quarterly reports, and
isparities were manually re-checked with the original TB
egisters.
Patient characteristics included case detection strategy, age,
ender, district, TB category, bacteriological confirmation and
iabetes mellitus status. Treatment outcomes were classified as
avorable (treatment completed and cured) and unfavorable
utcomes (treatment failure, lost to follow up, died or not
valuated) (Table 1).
nalysis and statistics
Data were entered into Microsoft Excel (Microsoft, Redmond,
A, USA) and analyzed using STATA (version 12.1, copyright 1985–
011 Stata Corp LP USA).
Comparison of demographic and clinical characteristics of
atients detected using ECS and PCF was done using χ2 test. The
ase finding strategy (ECS or PCF) was our exposure of interest and
he treatment outcome (unfavorable or favorable) was our
utcome of interest. We used log binomial regression models to
ssess the association between ECS and unfavorable outcome after
djusting for potential confounders, giving crude and adjusted
elative risk (95% CIs).
esults
We included 79 431 persons with PTB of whom 4604 (5.8%) were
etected by ECS; of these a total of 4052 (88%) were bacteriologically
onfirmed, with a similar proportion in both household (3058/
477 = 87.9%) and community contacts (994/1127 = 88.2%). Out of
052 bacteriologically confirmed patients, 3573 (88.2%) were
ositive on smear microscopy only, 172 (4.2%) on Xpert only (of
hese 160 were microscopy negative and 12 had no microscopy
esult) and 307 (7.6%) were positive on both. We do not have similar
nformation for the PCF group.
The baseline characteristics of the PTB patients detected by ECS
by routine PCF are shown in Table 2. The mean age was 36 years
and standard deviation 18 years for both groups. There were more
males (56.2%) in the ECS group than in the PCF group (49.6%,
P < 0.001). In the ECS group, bacteriological confirmation was
higher (88.0%) than in PCF group (36.5%, P < 0.001) and the history
of previous TB treatment was lower (0.5%) compared to the PCF
group (6.4%, P < 0.001).
We have depicted the treatment outcomes for all patients,
bacteriological confirmed PTB patients, and clinically diagnosed
PTB patients, and stratified by case finding strategy in Table 3. On
crude analysis, the proportion with unfavorable outcomes was
lower in the ECS group when compared to PCF in all three groups,
but was significantly lower among bacteriologically confirmed PTB
in the ECS group (9.9%) compared to PCF (11.6%; (P < 0.05). Among
all PTB patients, there was a higher contribution of cure to
treatment success in the ECS group (48.1%) when compared to PCF
(18%). The ECS patients identified by Xpert (160) had outcomes
similar to those in Table 3: cured 86 (54%), completed 59 (37%),
died 1 (1%), lost to follow-up 7 (4%), not evaluated 7 (4%).
Among the bacteriologically confirmed patients in the ECS
group those detected in the index household had similar
unfavorable outcomes (85 of 994; 9%) to those detected in the
community (316 of 3058; 10%) (P = 0.06, data not in the tables). In
clinically diagnosed cases, the difference in proportions was also
not significant (7.2% household vs 8.9% community).
Less than 5% of patients were enrolled at private hospitals in
both groups, the same protocol was followed for these patients,
and no difference was observed.
Table 4 shows the association between the case finding strategy
and unfavorable outcomes after adjusting for potential confound-
ers. ECS was associated with lower unfavorable outcomes for all
PTB patients and this was statistically significant. A similar
association was observed in the bacteriologically confirmed PTB
patient group with a lower risk of unfavorable outcomes (adjusted
relative risk 0.91; 95% CI 0.82–1.00) compared to routine case
finding; this association was not statistically significant in the
clinically diagnosed PTB cohort.
Discussion
In this large study from 4 districts of Pakistan, we found that the
treatment outcomes among PTB patients detected by ECS were
similar to those detected by PCF. While the ECS group was
associated with a marginally lower risk of unfavorable outcomes
among bacteriologically confirmed PTB patients, this was not the
case among clinically diagnosed patients.
This study had several strengths. It was the first study in
Pakistan to evaluate the treatment outcomes of PTB patients
able 1
perational definitions of TB treatment outcomes used in Pakistan’s national TB program (2013-15).
Outcome Definition
End of treatment
Cured A pulmonary TB patient with bacteriologically confirmed TB at the beginning of treatment who was smear- or culture-negative in the last
month of treatment and on at least one previous occasion.
Treatment completed A TB patient who completed treatment without evidence of failure BUT with no record to show that sputum smear or culture results in the
last month of treatment and on at least one previous occasion were negative, either because tests were not done or because results are
unavailable.
Treatment failed A TB patient whose sputum smear or culture is positive at month 5 or later during treatment.
Lost to follow-up A TB patient who did not start treatment or whose treatment was interrupted for two consecutive months or more.
Died A TB patient who dies for any reason before starting or during the course of treatment.
Not evaluated A TB patient for whom no treatment outcome is assigned. This includes patients “transferred out” to another treatment unit as well as
patients for whom the treatment outcome is unknown to the reporting unit.
Favorable outcome The sum of cured and treatment completed




Characteristics of patients with pulmonary tuberculosis in 4 districts of Pakistan detected by passive case finding and by extended contact screeninga, 2013-15.
Extended contact screening Passive case finding p value*
n (%) n (%)
Total 4604 (100) 74,827 (100)
Demographic characteristics
Age in years 0.971
<15 391 (8.4) 6508 (8.7)
1544 2613 (56.8) 42,384 (56.6)
4564 1192 (25.9) 19,293 (25.8)
65 408 (8.9) 6642 (8.9)
Sex
Male 2587 (56.2) 37,144 (49.6) <0.001
Female 2017 (43.8) 37,683 (50.4)
District
Lahore 1994 (43.3) 33,375 (44.6) <0.001
Faisalabad 1619 (35.2) 19,611 (26.2)
Rawalpindi 899 (19.5) 19,551 (26.1)
Islamabad 92 (2.0) 2290 (3.1)
Clinical characteristics
Classification by laboratory
Bacteriologically confirmed 4052 (88.0) 27,299 (36.5) <0.001
Clinically diagnosed 552 (12.0) 47,528 (63.5)
Type of patient
New patient 4579 (99.5) 70,090 (93.6) <0.001
Previously treated 25 (0.5) 4737 (6.4)
Diabetes Mellitus status
Yes 192 (4.2) 3176 (4.2) 0.419
No 4412 (95.8) 71,651 (95.8)
* Chi square test.
a Community screening within a 50-m radius of index case in addition to household screening.
Table 3
Comparison of treatment outcomes of people with pulmonary tuberculosis in 4 districts of Pakistan detected by passive case finding vs extended contact screeninga, 2013–15.
Treatment outcomes Extended contact screening Passive case finding P value* for unfavorable
outcome
n (%) n (%)
All TB 4604 74,827
[N = 79,431]
Favorable (F) 4163 (90.4) 67,421 (90.1)
Unfavorable (U) 441 (9.6) 7406 (9.9) 0.480
Cured (F) 2217 (48.1) 13,496 (18.0)
Treatment completed (F) 1946 (42.3) 53,925 (72.1)
Treatment failed (U) 39 (0.9) 485 (0.6)
Died (U) 93 (2.0) 1183 (1.6)
Lost to follow up (U) 203 (4.4) 4185 (5.6)
Not evaluated (U) 106 (2.3) 1553 (2.1)
Bacteriologically confirmed 4052 (100) 27,299 (100)
[N = 31,351]
Favorable (F) 3651 (90.1) 24,126 (88.4)
Unfavorable (U) 401 (9.9) 3173 (11.6) 0.001
Cured (F) 2217 (54.7) 13,496 (49.5)
Treatment completed (F) 1434 (35.4) 10,630 (38.9)
Treatment failed (U) 39 (0.9) 298 (1.1)
Died (U) 91 (2.3) 679 (2.5)
Lost to follow up (U) 171 (4.2) 1344 (4.9)
Not evaluated (U) 100 (2.5) 852 (3.1)
Clinically diagnosed [N = 48,080] 552 (100) 47,528 (100)
Favorable (F) 512 (92.8) 43,295 (91.1)
Unfavorable (U) 40 (7.2) 4,233 (8.9) 0.173
Treatment completed (F) 512 (92.7) 43,295 (91.0)
Treatment failed (U) 0 (0) 187 (0.4)
Died (U) 2 (0.4) 504 (1.0)
Lost to follow up (U) 32 (5.8) 2841 (5.9)
Not evaluated (U) 6 (1.1) 701 (1.4)
* Chi square test.
a Community screening within 50-m radius of index case in addition to household screening.




















































M. Ul Haq, S.G. Hinderaker, R. Fatima et al. International Journal of Infectious Diseases 104 (2021) 634–640etected by the ECS strategy and compare with routine PCF. We
ad a large sample size of PTB patients enrolled for treatment in 4
ighly populated urban districts with slums. This was the first time
hat Xpert MTB/RIF assay was used to improve bacteriological
onfirmation among smear negative contacts in Pakistan. Also,
ata related to case notification of both ECS and PCF were obtained
rom routine data recorded at NTP sites; findings therefore
eflected conditions on the ground.
The study had a number of limitations. Some patients detected
y ECS may have been wrongly categorized as PCF in TB registers at
he health facility, but not vice versa. We see no reason why these
ew wrongly categorized patients should have different outcomes,
nd hence bias our results. By slightly reducing the sample size of
he smallest group it might marginally reduce the statistical power.
e believe that there were other predictors of TB treatment
utcomes in our setting which could not be assessed, as these were
ot routinely captured by the NTP in the study period; examples
ould be severity of disease, socioeconomic status, nutritional
tatus, and smoking. Therefore, residual confounding cannot be
uled out. The TB recording and reporting system had no data
elated to patient HIV status. According to 2016 Integrated
iological Behavioral Surveillance Survey (IBBS) HIV prevalence
n Pakistan is low (0.12%) and limited to special risk groups, such as
ntravenous drug users and sex workers. Our study included only
hose TB patients who were started on treatment–thus the impact
f pre-treatment loss to follow-up on overall outcomes could not
e assessed. It is possible that the ECS and PCF groups might have
xperienced different rates of pre-treatment losses and this might
ave influenced the treatment outcomes. This is a limitation and
e are unable to quantify its impact on overall results. Another
imitation might be related to the differences in the way Xpert was
sed in the 2 groups. While about 12% of patients in the ECS group
eceived an Xpert test (and thus the rifampicin resistance was
xcluded), we do not know what proportion of the patients in PCF
roup had received Xpert and had rifampicin resistance excluded
rior to first-line treatment. This might have introduced a bias
aking the 2 groups different and might have impacted outcomes.
Our study suggests that the treatment outcomes among PTB
atients in the ECS group are not inferior to that of the PCF group.
he marginally better outcomes in bacteriologically confirmed
There may be some sort of Hawthorne effect, where partic-
ipants in our ECS group got (perhaps marginally) more attention
from the health system facilitating better follow up compared with
routine TB control. Our study results are similar to recent studies in
India and Myanmar, which showed no difference in treatment
outcomes; in India the proportion of unfavorable outcomes was
10.2% in the ACF and 12.5% in the PCF group (P = 0.468), in Myanmar
the proportions were respectively 12.4% and 14.6% with no
significant differences found between ACF and PCF (Khaing
et al., 2018; Shewade et al., 2019). A systematic review in 2013
also found no difference in the treatment outcomes for both groups
(Lönnroth et al., 2013). In contrast, another study from India found
worse treatment outcomes in ACF than PCF (33% vs 14%) (Singh
et al., 2020). These studies had smaller sample size and did not use
Xpert MTB/RIF among smear negative contacts, as we did in our
study.
Conclusion and recommendations
In conclusion, we found that treatment outcomes among PTB
patients detected by ECS were not inferior to those for patients
detected by PCF. Statistically, the ECS group had marginally better
outcomes among bacteriologically confirmed patients; but this
was driven by large sample size and we do not think these
differences are programmatically significant. These findings
should encourage stakeholders in Pakistan to support case finding
projects among household contacts and community contacts to
find and treat missed TB cases, to complement the indispensable
routine PCF.
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ffect of extended contact screeningc on unfavorable treatment outcomes when compared to passive case finding among people with pulmonary TB in 4 select districts,
akistan 2013-15.
Pulmonary TB Case finding strategy Total Unfavorable outcome RR (95% CI) aRRa (95% CI)
N n (%)
All TB
Extended contact screening 4604 441 (9.6) 0.97 (0.88, 1.06) 0.90 (0.82, 0.99)b
Passive case finding 74,827 7406 (9.9) Ref
Bacteriologically confirmed
Extended contact screening 4052 401 (9.9) 0.85 (0.77, 0.94) 0.91 (0.82, 1.00)b
Passive case finding 27,299 3173 (11.6) Ref
Clinically confirmed
Extended contact screening 552 40 (7.3) 0.81 (0.60, 1.10) 0.79 (0.59, 1.07)
Passive case finding 47,528 4233 (8.9) Ref
B – Tuberculosis.
a Log binomial regression, adjusted for potential confounders (age, sex, district, previous treatment and classification by laboratory), age and gender were adjusted as they
re universal confounders. Diabetes status was not associated with outcome of interest but associated with the exposure of interest (case finding and therefore not a potential
onfounder.
b P < 0.05.
c Community screening within a 50-m radius of index case in addition to household screening.atients may be due to better follow-up in the ECS group (reflected
y the lower rates of patients not evaluated for outcomes) and
ossibly better exclusion of rifampicin resistance before starting
reatment. Overall, we feel that the differences are marginal and
hough statistically significant (driven by large sample size), they
re not programmatically significant.63Ethics
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